← Evidence map

Observational studyClinical pharmacology and therapeutics2020

Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol.

Nisanne S Ghonem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

29 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32480421